Literature DB >> 1955564

Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system.

D J Carr1, B R De Costa, L Radesca, J E Blalock.   

Abstract

The existence of sigma receptors on lymphocytes and thymocytes was characterized using [3H](+)-pentazocine. [3H](+)-Pentazocine specifically labels high affinity sigma-type binding sites on T- and B-enriched lymphocyte membranes. The binding is saturable with T lymphocyte sites having a KD value of 401 +/- 85 nM and B lymphocyte sites having a KD value of 302 +/- 46 nM. Likewise, saturable high (KD1 277 +/- 92 nM) and low (KD2 2.5 +/- 1.2 microM) affinity sites for [3H](+)-pentazocine are found on thymocytes as well. In competition studies with lymphocytes, the rank order of potency for competing ligands is (+)-pentazocine = N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2- (1-pyrrolidinyl)ethylamine (BD1008) greater than 1R,2S-(+)-cis-N-(2-(3,4-dichlorophenyl)ethyl]-2- (1-pyrrolidinyl)cyclohexylamine (LR132) greater than or equal to (-)-pentazocine greater than or equal to phenazocine greater than (+/-)-trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide methanesulphonate (U-50,488H) = phencyclidine greater than haloperidol = 1,3-di- (o)-tolylguanidine. In competition studies with thymocytes, the rank order of potency for competing ligands is (+)-pentazocine = BD1008 greater than or equal to phenazocine greater than haloperidol greater than 1,3-di-(o)-tolylguanidine greater than phencyclidine greater than (-)-pentazocine. These compounds were also investigated as potential regulatory molecules in mitogen-stimulated lymphocyte proliferation assays. Of the compounds tested, phencyclidine, 1,3-di-(o)-tolylguanidine, haloperidol, and (+)-pentazocine suppress concanavalin A-induced proliferation at high (10(-5) M) concentrations while (-)-pentazocine is inactive. When pokeweed mitogen or lipopolysaccharide are used, these compounds enhance or suppress lymphocyte proliferation depending on the mitogen and concentration of ligand. These results indicate a stereoselective receptor for (+)-pentazocine which is coupled to biological processes of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955564     DOI: 10.1016/0165-5728(91)90170-c

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

2.  A sigma ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice.

Authors:  B Bourrié; J M Benoît; J M Derocq; M Esclangon; C Thomas; G Le Fur; P Casellas
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

3.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

4.  The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae.

Authors:  S Silve; P Leplatois; A Josse; P H Dupuy; C Lanau; M Kaghad; C Dhers; C Picard; A Rahier; M Taton; G Le Fur; D Caput; P Ferrara; G Loison
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

5.  Sigma receptors suppress multiple aspects of microglial activation.

Authors:  Aaron A Hall; Yelenis Herrera; Craig T Ajmo; Javier Cuevas; Keith R Pennypacker
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

6.  Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes.

Authors:  C Pignatti; I Stanic; C Stefanelli; B Tantini; C Rossoni; F Flamigni
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

7.  Immunoregulatory properties of (+)-pentazocine and sigma ligands.

Authors:  D J Carr; S Mayo; T W Woolley; B R DeCosta
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

8.  Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation.

Authors:  Miguel A Iñiguez; Carmen Punzón; Raquel Nieto; Javier Burgueño; José M Vela; Manuel Fresno
Journal:  Front Pharmacol       Date:  2013-03-13       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.